Skip to main content

Eleva Capital SAS

SEC CIK
0002054496
Latest filing
Jul 2, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Eleva Capital SAS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q3 2025)
31,339
Value
$1.70M
% of portfolio
0.4%
Quarters held
2
Since Q2 2025
Holdings of BMRN by Eleva Capital SAS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025––––Not filedHolders
Q3 202531,339$1.70M0.4%+7,920+33.8%AddedHolders
Q2 202523,419$1.29M0.3%–No prior filingHolders